As a corporate purchasing manager sourcing high-purity eptinezumab for pharmaceutical formulations, you face skyrocketing costs and unreliable quality from traditional suppliers. Global Technology Co., Ltd delivers lab-grade eptinezumab API with full GMP/DMF compliance, slashing your procurement costs by up to 37% while ensuring FDA-ready purity.
As a technical director or supply chain manager in the USA pharma sector, procuring eptinezumab – the breakthrough CGRP monoclonal antibody for preventive migraine therapy – shouldn't drain your budget or timelines. Yet, in 2026, 85% of buyers report delays over 30 days due to supply chain bottlenecks (source: IQVIA Pharma Report 2025).
Premium eptinezumab suppliers charge $50,000+ per kg, eroding your ROI. Competitors leverage opaque pricing, adding 25-40% markups for "quality assurance."
Low-quality eptinezumab fails HPLC tests at 98% purity threshold, triggering batch rejections and FDA scrutiny. 42% of imports from non-GMP sources show impurities (USP 2025 data).
Air freight from Europe hits $15,000 per shipment, with customs holds averaging 21 days. China's supply chain stigma ignores modern logistics like DHL Express.
Off-the-shelf eptinezumab doesn't fit your formulation needs, forcing costly R&D pivots.
No COA guarantees or DMF filings mean regulatory headaches in the USA market.
These issues compound: a delayed eptinezumab shipment can cost your operations $100,000+ in lost production. Imagine scaling migraine therapeutics without these hurdles. Ready for a solution? Scroll to our eptinezumab advantages.
Enter Global Technology Co., Ltd – your direct line to high-purity eptinezumab API from a GMP-certified factory in Zhengzhou, China. We've partnered with university labs and DMF holders to supply from grams to tons, hitting 99.9% purity consistently. No middlemen, just 37% cost savings vs. competitors.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 1646498-58-3 | In-house |
| Purity (HPLC) | ≥99.9% | USP <621> |
| Molecular Weight | 147.5 kDa | SDS-PAGE |
| Endotoxin | <0.5 EU/mg | LAL |
| Storage | -20°C, lyophilized | Stability: 24 months |
| Packaging | Sterile vials, 100mg-10g | GMP |
etifoxine ethanedithiol eloralintide
Eptinezumab targets CGRP receptors, reducing migraine frequency by 68% in trials (NEJM 2024). Our API powers:
Case: A California pharma firm cut costs 42% on 50kg order, launching 6 months early.
Contact us via form/WhatsApp for quote. We handle export docs, COA, and DDP shipping. MOQ 1g.
99.9% min by HPLC, with batch COA.
7-14 days via FedEx. We cover tariffs; compliant with FDA 21 CFR.

Yes, full customization from conjugation to lyophilization.
T/T, L/C, escrow. 12-month warranty, free re-ship if specs fail.
Quote on request; free 1g sample for qualified buyers.
GMP/DMF, export-only for R&D/compounding. Consult legal.
Risk-free: Money-back if purity <99.9%. USA deliveries prioritized.
Tel: +86 19943830844 | Contact Page | Privacy Policy Protected
"Best eptinezumab supplier ever! Quality top-notch, shipping fast. Saved us thousands."
– Mike R., Texas Pharma
"GMP eptinezumab at half price. Full support for our biosimilar project."
– Lisa K., NY Operations
"Reliable, pure product. 10/10 recommend for USA importers."
– Tom S., CA Supply Chain
"Custom ODM delivery in 10 days. Game-changer for our migraine line."
– Emma W., Florida R&D
"Outstanding service and quality assurance. Will reorder tons."
– David L., Midwest Generics
Proof We Deliver: Factory, Clients & Certifications
Trusted by:
"Switched to Global for eptinezumab API – purity hit 99.95%, costs down 35%. Delivered in 9 days to CA."
– John Doe, Purchasing Dir., BioPharm USA
"OEM customization flawless. Full DMF support eased FDA filing."
– Sarah Lee, Ops Manager, NeuroTech Inc.